Johns Hopkins ABX Guide
Clesrovimab
INDICATIONS
FDA
FDA
- Prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Canada permits consideration of off-label clesrovimab for high-risk children during a second season, even though the product is not authorized for that indication.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 10, 2026
Citation
, , and Caitlin Soto. "Clesrovimab." Johns Hopkins ABX Guide Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540817/all/Clesrovimab.
, Soto C. Clesrovimab. Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540817/all/Clesrovimab. Accessed October 12, 2026.
, ., & Soto, C. (2026). Clesrovimab. In Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540817/all/Clesrovimab
, Soto C. Clesrovimab [Internet]. In: Johns Hopkins ABX Guide Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 October 12]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540817/all/Clesrovimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clesrovimab
ID - 540817
A1 - ,,
AU - Soto,Caitlin,PharmD, BCIDP
Y1 - 2026/10/10/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540817/all/Clesrovimab
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
